For its first quarterly results since its IPO, Vicenne has an increase of 52 % of its turnover. A performance that validates the robustness of the defended model when it goes on the stock market.
A few months after his noted arrival on the stock market, Vicenne reveals his first consolidated results and succeeded in his first test against the market. The group, specializing in the integration of technological health solutions, recorded in the second quarter of 2025 a turnover of 527 million dirhams, up 52% compared to the same period of the previous year. At the semester level, growth reaches 44%, reflecting acceleration far beyond market expectations.
This dynamic validates the narrative exposed during the IPO. Vicenne shows that its full integrator positioning, between equipment, consumables and services, allows it to capture the structural growth of the medical sector.
In detail, the income from equipment increased by 43%, those of the implantable and reactive jump by 52%, while the services display an increase of 33%over a year. Performance is accompanied by a financial discipline. Net debt, excluding leasing, remains stable compared to 2024 despite the increase in activity volumes, while the leasing outstanding remains almost unchanged.
Investments (CAPEX) recorded in the first half are mainly related to operations related to the IPO, which reflects measured management of resources. The group also maintains its annual objectives, consistent with the business plan presented to investors.
Successful bet for Vicenne, which reflects its fundraising in concrete projects, whether it be the incineration of hospital waste or the digitalization of technical services. If the first results testify to a promising trajectory, the value that investors will grant it will now depend on the operational rigor and the effective implementation of its strategic plan.
Ayoub Ibnouldssih / Eco inspirations
